The Texas State Department of State Health Services Immunization Unit strives to prevent disease, disability, and death in children, adolescents, and adults through vaccination. What are the state’s most pressing challenges? During this session, the speaker will address how the state is moving forward with various programs and services to keep Texans healthy.
While individuals can achieve success, they can still feel the impact of challenges to moving forward. During this session, the presenter will list one accomplishment and one challenge for immunization programs, as well as identify one action for a program to increase immunization rates or improve systems. The session will also include an overview of vaccination rates in the United States (and Texas) followed by a discussion of focal immunization challenges. At the end, attendees will have the tools to help improve immunization rates.
Vaccines have been instrumental in improving the health of the world’s population. Despite the remarkable success of past immunization efforts, the state and nation still face significant obstacles to continuing and growing current immunization practices. This presentation will include discussion of current efforts and expected outcomes in Texas, as well as highlight goals for Texas’ immunization system.
The Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). HPV is so common that nearly all sexually active people get it at some point in their lives. This session will provide an overview of the burden of HPV, including HPV infection rates, HPV-related cancer rates, and HPV vaccination rates. Data will include national, state and local estimates of the HPV burden, and presentation of methods for estimating local burden. An overview of some of the national, state and local activities and opportunities related to HPV and HPV-related cancer prevention and control will be provided, including resources and tools that can be readily implemented.
During this session, the presenters will discuss the Federal and Texas Vaccines For Children Program, National Immunization Survey (NIS) coverage levels for children and adolescents and increasing adult immunization rates through participation in Adult Safety Net (ASN) Program as well. Presenters will also cover the 2018 TVFC Program Updates, National Immunization Survey (NIS) updates for the United States and Texas and Adult immunization initiatives including Adult Safety Net (ASN) Program.
On April 3, 2017, the Department of State Health Services (DSHS) Immunization Unit launched ImmTrac2, the new Texas Immunization Registry. A secure and confidential registry, ImmTrac2, safely consolidates and stores immunization information from multiple sources electronically in one centralized system. During this session, attendees will have the opportunity to ask questions and meet with Subject Matter Experts from the ImmTrac Group to discuss new system functionalities with ImmTrac2 and the benefits to providers. Program area specialists will discuss updates to Data Exchange capabilities and implementation to Meaningful Use 3 standards.
Each year, the Advisory Committee on Immunization Practices (ACIP) approves immunization schedules recommended for persons living in the United States. The adult immunization schedule provides a summary of ACIP recommendations on the use of licensed vaccines routinely recommended for adults aged 19 years or older. During this session, attendees will be updated on the rates of adult immunization and Human Papillomavirus (HPV) vaccinations in Texas and identify mechanisms used to share these rates with stakeholders. The presenter will cover adult immunization rates, HPV vaccine rates and collaborations to educate stakeholders on the rates in Texas and within their communities. The session will also cover efforts to address these rates at a state and a community level and efforts used to address these rates and to increase immunizations.
This session will provide an overview of current vaccine coverage estimates for children in Texas. The presenter will focus on data from the 2016 childhood, teen, and flu National Immunization Surveys (NIS) as well as data from the 2016-17 Annual Report of Immunization Status (school data). The data from a variety of surveys provide a comprehensive picture of vaccination coverage across the pediatric population and identifies gaps in that coverage. The presenter will include data from: --The CDC annual family survey to assess vaccination coverage at the national, state, and select jurisdictional level. --The NIS survey of parents and providers of children 19-35 months to assess coverage for the childhood immunization schedule. --NIS-Teen survey of parents and providers of adolescents 13-17 to assess coverage for Tdap, meningococcal vaccine, and HPV, as well as catch up coverage for MMR and varicella. NIS-Flu combines flu vaccine data from the above surveys and also includes data for children 6-18 months and 3-12 years. --The Annual Report of Immunization Status survey of all public school districts and private schools to ascertain compliance with vaccination requirements. The Report focuses on Kindergarten and 7th grade, and provides data on vaccination coverage, exemptions, and provisionally enrolled students.
Acute flaccid myelitis (AFM) is an acquired, serious, acute spinal cord disease with some similarity to polio and some similarity to post-infectious myelitis. This has been seen in association with a specific enteroviral outbreak in the United States in the last 10 years. During the last few years, there have been recent cases of AFM in children in Texas. This is an evolving complex medical illness that is being tracked currently by the Department of State Health Services (DSHS) nd the Centers for Disease Control and Prevention (CDC). The speakers will review several recent cases over the last year from Dell Children’s Medical Center in Austin Texas, and review further epidemiology from DSHS and CDC. The session will address about the association with viral illness, pattern of clinical illness, laboratory and imaging findings and review treatments that had been used, as well as outcomes.
The Texas Vaccines for Children (TVFC) and the Adult Safety Net (ASN) Programs are committed to providing quality vaccine coverage in partnership with local health departments and healthcare providers through proper vaccine storage and handling. During this session, participants will be presented with vaccine storage and handling best practices, as recommended by the Texas Department of State Health Services (DSHS) Immunization Unit and the Centers for Disease Control (CDC). Discussion will include strategies and an overview of equipment needed to foster vaccine stability, vaccine transport protocols, temperature excursions, and temperature monitoring process and devices.
This session will introduce attendees to the Texas HPV Coalition. Key takeaways will include: an understanding of who is on the coalition, how the coalition works, review its objectives are, and how to get involved. Additionally, speakers will share information on the new nationwide HPV campaign, launching this February by the National HPV Roundtable and the American Cancer Society. The Texas HPV Coalition’s mission seeks to work together to prevent HPV-associated cancers and pre-cancers by increasing HPV vaccination rates statewide. Members work to share information, identify needs and opportunities, and enhance programs, activities, and services relating to HPV vaccination. The strength of our partnership, united in mission, enhances the work of each member and thus effectively furthers the case of eliminating HPV vaccine-preventable cancers in Texas.
The Department of State Health Services (DSHS) Immunization Unit launched ImmTrac2, the new Texas Immunization Registry on April 3, 2017. ImmTrac2 is a secure and confidential registry that safely consolidates and stores immunization information from multiple sources electronically in one centralized system.(new line)This session will focus on Texas adults, Texas State Law pertaining to Minor/Adult Consent, and the benefits of ImmTrac2. Attendees will have the opportunity to address questions and meet with Subject Matter Experts from the ImmTrac Group to discuss new system functionalities with ImmTrac2 and the benefits to providers. Program area specialists will discuss updates to Data Exchange capabilities and implementation to Meaningful Use 3 standards.
School-based vaccination programs keep students in school and families healthy, while providing financial benefits to communities. During this session, speakers will identify strategies for addressing high-priority vaccine delivery needs in Texas and examine the reasons for undertaking school-based immunization programs. Attend to hear from experts about three different models for in-school vaccine delivery programs and those programs’ strengths and challenges.
Maternal immunization is recommended to protect both mother and young infants from vaccine-preventable diseases. The rationale for maternal immunization is built on the concept of passive protection; women mounting an IgG response after immunization with a vaccine have placental transport of protective antibodies that prevent infection during early infancy. During this presentation, the speakers will describe the logistical and biological considerations that are necessary to implement a maternal immunization platform. Maternal immunization against influenza and pertussis is recommended for all pregnant women in the United States. Speakers will discuss the evidence specific to these recommendations and describe studies that demonstrate their effectiveness. Despite these recommendations, vaccination rates are sub-optimal in pregnant women. The speakers will address possible reasons for this and offer strategies to improve vaccination rates in pregnant women.
The Vaccine-Preventable Disease (VPD) Team will be providing an update on VPDs throughout the state of Texas over the past year. This will include a discussion of outbreaks, clusters, and notable investigations of VPDs as well as trends and new public health recommendations for control measures. There will also be a brief question and answer session at the end of the presentation for session attendees.
The Texas Vaccines for Children (TVFC) Program is committed to providing low-cost vaccines, removing barriers, and increasing accessibility to vaccines to eligible children from birth to 18 years of age. With a mission to increase vaccine coverage levels and reduce the burden of vaccine-preventable diseases for all Texas infants, children, and adolescents, the TVFC Program continues to succeed due to partnerships between the Texas Department of State Health Services (DSHS), local health departments, healthcare providers, and patients. During this session, participants will be presented with TVFC Program updates focused on increasing the knowledge and understanding of program policies and requirements.
Immunization is a vital public health tool and one of the most cost-effective means of public health promotion and disease prevention. This session will discuss the newest developments on immunization policy at the state and federal level. The speakers will discuss uncertainties in federal and state immunization policy and what entities impact policy formation, as well as what may transpire in the future to affect immunization policy development.
The Texas Department of State Health Services (DSHS) Immunization Unit is committed to removing barriers to vaccines and improving vaccination coverage rates for adults in Texas. Through the continued development and strengthening of partnerships between DSHS, local health departments, healthcare providers, and patients, the DSHS Immunization Unit continues to focus on improving and expanding healthcare providers’ knowledge and utilization of the DSHS Adult Safety Net Program (ASN) and the Centers for Disease Control (CDC) Standards for Adult Immunization Practice. During this session, participants will be presented with strategies focused on increasing the number of healthcare providers offering and administering ACIP-recommended adult immunizations, increasing the utilization of ImmTrac2, the Texas Immunization Registry, to record immunizations for consented adults, and increasing the awareness and importance of adult immunizations among the general public and healthcare providers.
The Department of State Health Services (DSHS) Immunization Unit launched ImmTrac2, the new Texas Immunization Registry on April 3, 2017. ImmTrac2 is a secure and confidential registry that safely consolidates and stores immunization information from multiple sources electronically in one centralized system. This session will focus on Texas children and adolescents, Texas State Law pertaining to Minor/Adult Consent, and the benefits of ImmTrac2. Attendees will have the opportunity to address questions and meet with Subject Matter Experts from the ImmTrac Group to discuss new system functionalities with ImmTrac2 and the benefits to providers. Program area specialists will discuss updates to Data Exchange capabilities and implementation to Meaningful Use 3 standards.
The objective of this program is to increase the professional’s confidence and comfort level in discussing immunizations with parents, answering their questions, and responding to their concerns. Attendees will learn about specific communication techniques for addressing common objections of vaccine-hesitant parents—and will see those techniques demonstrated by our expert faculty.
Mumps is an acute viral illness that classically presents with parotitis. Infected persons who are asymptomatic or have non-specific respiratory symptoms (~30 percent) can also transmit disease. The United States experienced a 99 percent reduction in mumps cases by 2005 following implementation of a two-dose MMR vaccination program in 1989. In recent years, mumps cases and incidence rates have increased, with most cases occurring among young adults (18-25 years). Outbreaks are occurring in close contact settings such as universities and within highly vaccinated populations. In 2016, there were 3,366 cases of mumps reported, the highest in a decade. High rates of the disease continued into 2017. This presentation will describe current mumps epidemiology trends within the United States, highlighting mumps case demographics, incidence rates and outbreak data.
Maximum Stock Level (MSL) determines the amount of vaccine a TVFC or ASN provider can order. In this portion of the session, the speakers will review how the MSL is calculated and applied, MSLs for new providers, and the frequency that MSLs are updated. After this presentation, attendees will have a better understanding of how MSLs are calculated and utilized, how to best utilize the monthly MSL emails and the connection between the MSL and suggested quantities.(new line)Speakers will also address vaccine return. In this portion of the session, they will describe vaccine loss, what the requirements are around vaccine loss, and how vaccine loss is processed. The speakers will discuss where the most issues occur when processing loss and how to minimize these issues. After this presentation, attendees will have a better understanding of the vaccine loss requirements, why they are in place and how loss is processed.
This session will explain what immunization coalitions are and the valuable role they play in communities. In 2017, The Immunization Partnership partnered with the Texas Department of State Health Services Immunization Unit to provide coalition capacity building services to six immunization coalitions across the state. The case study will provide an in-depth look at the impact of those services on the Gregg County Vaccine Awareness Coalition in Longview, Texas.
Since the introduction of the seven-valent pneumococcal conjugate vaccine in 2000 (PCV-7) followed by PCV-13 in 2010 for routine administration to infants, the incidence of invasive pneumococcal disease (IPD) such as bacteremia, pneumonia and meningitis in children has decreased substantially. Currently, most IPD is now due to non-PCV-13 serotype isolates. In addition, important decreases in local infections associated with S. pneumoniae such as acute otitis media and sinusitis have occurred. The frequency of antibiotic resistant pneumococcal isolates also has declined. The speakers will discuss how non capsular polysaccharide antigens are being considered in the development of next generation pneumococcal vaccines.
There is an abundance of behavioral research on effective (and ineffective) communication techniques aimed at increasing vaccine confidence among the public. As vaccine advocates, it is our job to wade through this research (which often contradicts previous studies and often seems counter-intuitive) to develop effective communications. Every Child By Two, has been highly successful at reaching the public through social media and communication efforts. This session will feature behavioral research that has helped to inform ECBT’s Vaccinate Your Family program components, which are reaching up to 11 million people each year on social media.
The field of immunization is marked by frequent changes including annual Advisory Committee on Immunization Practice (ACIP) immunization schedules, ACIP updated recommendations and newly licensed vaccines. Staying current can be a challenge for immunization providers and their staff. The purpose of this presentation is to provide an update on 2017 ACIP immunization recommendations for children and adults. Best practice standards and strategies, as well as, related clinical resources and job aids will be discussed.
Have vaccines been so effective that Americans have forgotten the dangers of diseases such as measles, smallpox, and polio? The vaccines of Dr. Maurice Hilleman changed American history – yet few individuals know his name. Hilleman – A Perilous Quest to Save the World’s Children is a documentary film that explores the life, achievements, and motivations of the scientist responsible for eight of the vaccines that protect individuals today. The film considers how the threat of infectious disease in America drove both scientists and citizens to prioritize vaccine initiatives. A panel discussion, moderated by Dr. Richard Rupp, will explore how history and collective memory impact decisions about vaccination today.
Nothing tells the history of struggle better than a personal account. During this session, attendees will learn the epidemiology of Human papillomavirus (HPV) through a survivor’s story. The speaker will explain first hand, why it is so important to vaccinate. The session will also cover strategies to improve vaccination rates.
“May you live in interesting times.” This ancient Chinese curse may aptly apply to the state of childhood vaccinations today. Vaccine advocates worldwide have been scratching their heads for the past 20 years wondering why any parent would knowingly decline potentially life-saving protection for his or her child. Perhaps the greatest irony of vaccine success is that parents today have no fear of vaccine-preventable diseases. For today’s parents, the perceived risk of vaccines is greater than the real risk of the diseases. This lecture explores the evolution of modern day vaccine hesitancy and offers attendees specific, effective evidence-based solutions to vaccine conversations with parents. Pediatrician, acclaimed child health advocate, author of the Baby 411 book series, and spokesperson for the American Academy of Pediatrics, Dr. Ari Brown, presents a lively, fresh, and inspiring perspective of being a pediatrician in the trenches in today’s vaccine-phobic society. Prepare to leave this lecture with renewed enthusiasm to educate families about the importance of vaccines.
Human papillomavirus (HPV) vaccine uptake in the United States continues to be suboptimal, and the reasons for hesitance to vaccinate adolescents against HPV are multi-faceted. This presentation will present the most common misperceptions about HPV vaccine along with a discussion of the potential impact of these misperceptions. These include concerns about vaccine safety, effectiveness, need for vaccination in an environment of cervical cytology, sexual activity after vaccination, and long-term effectiveness. For each concern, the current evidence addressing these misperceptions will be presented. This information can be used to assist clinicians and public health professionals to have the tools to address parental concerns about HPV vaccine.